Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the October 13, 2015, Federal Register, FDA announced that it is withdrawing approval of 67 new drug applications ("NDAs") and 128 abbreviated new drug applications ("ANDAs") from multiple applicants.
United StatesFood, Drugs, Healthcare, Life Sciences
In the October 13, 2015, Federal Register, FDA
announced that it is withdrawing approval of 67 new drug
applications ("NDAs") and 128 abbreviated new drug
applications ("ANDAs") from multiple applicants. The
holders of the applications notified the Agency in writing that the
drug products were no longer marketed and requested that the
approval of the applications be withdrawn.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
